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We report the ﬁrst case of an endobronchial perineurioma, a rare benign neoplasm typically occurring in soft tissue. A 53-year-
old nonsmoking female presented with a three-month history of persistent bronchitis. A CT scan followed by bronchoscopy
demonstrated an endobronchial lesion involving the left mainstem bronchus. Removal of the lesion by bronchoscopy was
accomplished. The tumor was composed of bland spindle cells in a variably collagenized stroma. These cells had long cytoplasmic
processes. No mitotic activity or necrosis was observed. Neoplastic cells were immunoreactive for epithelial membrane antigen
(EMA), CD34, and claudin-1. Smooth muscle actin (SMA), desmin, and S-100 immunostains were all negative. Based on the
morphologic appearance and immunophenotype, a diagnosis of perineurioma was rendered.
1.Introduction
Perineuriomasarerarebenignneoplasmsrepresentingapro-
liferation of perineurial cells. Two distinct subtypes are rec-
ognizedandincludesofttissueperineuriomaandintraneural
perineurioma. Perineuriomas most commonly occur in the
dermisandsubcutisofthelimbsortrunk,butotherlocations
have been reported. Herein, we describe the ﬁrst case of soft
tissue perineurioma occurring in an endobronchial location.
2.CaseReport
A 53-year-old nonsmoking female presented to her primary
care physician with a three-month history of a nonresolving
upper respiratory infection. A chest-computed tomographic
(CT) scan demonstrated a 6mm endobronchial soft tissue
abnormality with slight contrast enhancement at the peri-
phery involving the left mainstem bronchus. Three-dime-
nsional reconstruction of CT images showed similar ﬁndings
(Figure 1).
Bronchoscopic evaluation showed an endobronchial
nodule involving the left mainstem bronchus (Figure 2). The
lesionwasremovedduringasubsequentbronchoscopy.ACT
scan, including three dimensional bronchial reconstruction
performed after a six month interval, showed no evidence of
a residual endobronchial lesion. The patient is well one year
following initial presentation.
3.MaterialsandMethods
Bronchoscopic biopsies were ﬁxed in 10% neutral buﬀered
formalin then subjected to routine processing and paraﬃn
embedding. Sections were stained with hematoxylin and
eosin.Immunohistochemicalstainswereperformedonpara-
ﬃnembedded tissueusing theavidin biotin peroxidasecom-
plex method (DakoCytomation Autostainer, Denmark).
Antibodies used are shown in Table 1.
4.Pathologic Findings
Sections of bronchial biopsies demonstrated a cellular prolif-
eration that was situated in submucosal tissue beneath his-
tologically unremarkable bronchial mucosa (Figure 3). The
unencapsulated proliferation of cytologically bland elon-
gatedspindlecellswasarrangedinastoriformpatternwithin
a collagenized stroma (Figure 4). No nuclear pleomorphism,
mitotic activity, or necrosis were noted. The spindle cell pop-
ulation expressed positivity for CD34, claudin-1 (Figure 5),2 Pathology Research International
Table 1: Panel of antibodies used for immunohistochemical analysis
Antibody Clone Company Antigen retrieval Dilution
Cytokeratin AE1/AE3 Dako Steam Prediluted
Desmin DE-R-11 Dako Steam Prediluted
EMA Monoclonal Dako Citrate buﬀer Prediluted
CD34 QBEnd 10 Dako Steam 1 : 25
SMA 1A4 Dako None Prediluted
S100 Polyclonal Dako Steam Prediluted
MyoD1 5.8A Dako Steam 1 : 50
CD117 T595 Biogenex Steam Prediluted
Claudin-1 Polyclonal Zymed Steam Prediluted
Figure 1: Three dimensional reconstructed CT image demonstrat-
ing an endobronchial soft tissue abnormality.
Figure 2: Bronchoscopic image demonstrating an endobronchial
nodule at the left mainstem bronchus.
and epithelial membrane antigen (EMA) (Figure 6). The
spindle cell population showed no staining for cytokeratin





Figure 3: Spindle cell proliferation situated beneath benign
bronchial mucosa. Hematoxylin and eosin.
Figure 4: Photomicrograph demonstrating a bland spindle cell
proliferation with a collagenized stroma. Hematoxylin and eosin.
characterized by an unencapsulated yet circumscribed pro-
liferation of bland spindle cells arranged in a storiform pat-
tern within a variably collagenized stroma. Ultrastructural
analysis demonstrates thin bipolar cytoplasmic processes,
junctional complexes, and smooth vesicles [1, 2]. In the
largestcaseseriesreported,HornickandFletcherreviewed81
cases of perineurioma. The majority of their cases occurred
in the dermis and subcutis of the limbs and trunk, having
a mean age of presentation in middle age with a slight
female predominance [1]. Hornick and Fletcher separatelyPathology Research International 3
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Figure 5: Spindle cells staining positively with claudin-1.
Figure 6: Spindle cells staining positively with epithelial membrane
antigen (EMA).
reported ten cases in the intestinal tract (nine colonic and
one jejunal) which presented as either polyps or submucosal
mass lesions [3]. Perineuriomas have furthermore been
reported in the stomach [4], kidney [5–7], lip [8], maxillary
sinus [8] and mandible [9]. Giannini et al. reported an
intraventricular perineurioma [10]. Perineurioma occurring
in an endobronchial location has never been reported.
Soft tissue and intraneural subtypes of perineurioma
have been described. Soft tissue perineurioma itself has three
types. The sclerosing variant of soft tissue perineurioma
presents as a small painless dermal or subcutaneous mass
involving the digits or palms of young adults [11]. It
is unique due to the presence of epithelioid perineurial
cells, extensive collagenization of the stroma and trabecular
growth pattern. It diﬀers from ﬁbroma of tendon sheath
which is associated with tendons. Sclerotic ﬁbroma expresses
factor XIIIa and collagen IV but not epithelial membrane
antigen (EMA) as would be seen in sclerosing perineu-
rioma. The reticular variant of soft tissue perineurioma
encompasses a group of perineuriomas having a prominent
lace-like reticular arrangement of lesional cells within a
variably myxoid stroma [12]. The diﬀerential diagnosis
of these lesions includes myoepithelial tumors, ossifying
ﬁbromyxoid tumor, extraskeletal myxoid chondrosarcoma,
myxoid malignant peripheral nerve sheath tumor, and
myxoid synovial sarcoma. The presence of EMA positivity
helps to diﬀerentiate the reticular variant of soft tissue
perineurioma from these other entities in most cases.
While myxoid synovial sarcoma is EMA positive, it also
tends to be positive for CD99 and bcl-2, markers which
would be absent in perineurioma. Finally, plexiform soft
tissue perineurioma is a very rare variant which must be
distinguished from multiple neoplasms having a plexiform
patternofgrowthsuchasplexiformneuroﬁbroma,plexiform
schwannoma, and plexiform circumscribed neuroma [13].
All of these tumors are typically S-100 positive and EMA
negative in contrast to perineurioma. In general, soft tissue
perineurioma must also be diﬀerentiated from dermatoﬁ-
brosarcoma protuberans (DFSPs), low-grade ﬁbromyxoid
sarcoma (LGFMS), desmoid tumor, ﬁbromatosis, and nerve
sheath tumors [14]. Biphasic tumors having a mixture of
either schwannoma or neuroﬁbroma, and perineurioma
have also been described and can present particular diﬃculty
[15]. There are also striking similarities between soft tissue
perineurioma and cutaneous meningioma, which in some
instances, can only be resolved by electron microscopy [16].
Since cases of soft tissue perineurioma have been reported in
the intestinal tract, gastrointestinal stromal tumor should be
excluded with a CD117 stain.
The second subtype of perineurioma is the intraneural
perineurioma, formerly referred to as localized hypertrophic
neuropathy [14, 17]. It has a distinct clinical presentation,
usually limited to a segment of nerve in the extremities. It is
characterized by complex wrapping of neoplastic perineurial
cells around endoneurial structures, resulting in the forma-
tion of pseudo-onion bulbs. Involvement of multiple nerve
fascicles produces a rope-like thickening of the nerve which
often results in loss of sensorimotor function. Malignant
transformationhasnotbeenreported,anditisnotassociated
with neuroﬁbromatosis.
Immunohistochemistry is pivotal in the accurate clas-
siﬁcation of perineurioma. The majority of perineuriomas
express EMA with variable expression of CD34 and smooth
muscleactin(SMA).Glut-1isahumanredbloodcellglucose
transporter which is expressed in perineurial cells. In their
study, Yamaguchi et al. demonstrated strong reactivity for
glut-1 in the ﬁve cases they reported [18]. No staining
for glut-1 was found for schwannoma, neuroﬁbroma or
cutaneous meningioma. The presence of claudin-1 staining
in perineuriomas has been reported to be 29% [10] to 92%
[19]. Claudins are a family of proteins that function in the
structure of the tight junction, and claudin-1 is expressed in
many body site locations. Folpe et al. did not ﬁnd claudin-1
reactivity in DFSP, LGFMS, or ﬁbromatosis; therefore, they
concluded that claudin-1 could be utilized in distinguishing
perineurioma from its mimics [19].
The clonal nature of intraneural perineurioma has been
conﬁrmedbydemonstratingalackofalloraportionofchro-
mosome 22 [17]. Deletion in chromosome 22 in soft tissue
perineurioma has also been reported and suggests that soft
tissueandintraneuralperineuriomasrepresentaspectrumof
perineurial neoplasia [14]. Deletion of chromosome 13 has
also been described in a large soft tissue perineurioma [9].4 Pathology Research International
Perineurioma is thought to represent a benign entity.
Hirose et al. reviewed 121 malignant peripheral nerve sheath
tumors (MPNSTs) from their ﬁles looking for cases having
perineurial diﬀerentiation [20]. A total of 23 cases were
selected for study based on the histologic ﬁndings of spindle
cells having long cytoplasmic processes present in whorls or
storiform arrangements typical of that seen in perineurioma.
These cases were subjected to immunostaining, and ﬁve
cases were found to have tumor cells which were S-100
negative and EMA positive. These authors emphasized
the importance of delineating perineurial diﬀerentiation in
MPNST because these tumors tend to have a more favorable
prognosis than conventional MPNST.
The case presented in this paper represents an endo-
bronchial perineurioma. While perineurioma usually occurs
in the skin and superﬁcial soft tissues, it has been reported
in unusual sites and should be considered in the diﬀerential
diagnosis of spindle cell lesions in any location.
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